Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146909 · ClinicalTrials.gov registry record · NA
The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04146909 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 7 participants.
The verdict
NCT04146909, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This purpose of this study is to investigate whether lactation improves insulin sensitivity and increases lipolysis in women.
Interventions
- DIAGNOSTIC_TEST Hyperinsulinemic-euglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-11-17 |
| Est. Completion | 2022-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04146909
The ClinicalTrials.gov registry entry for NCT04146909 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperinsulinemic-euglycemic clamp is the first listed.
NCT04146909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04146909 about?
NCT04146909 is a clinical study titled "The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women". This purpose of this study is to investigate whether lactation improves insulin sensitivity and increases lipolysis in women.
What is the current status of trial NCT04146909?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2020-11-17. Estimated completion is 2022-11-28.
What interventions are being tested in trial NCT04146909?
The interventions under investigation include: Hyperinsulinemic-euglycemic clamp (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04146909?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.